What Is Airway Remodeling and What Causes It?

Airway remodeling is the gradual, physical restructuring of the walls of your breathing passages. In diseases like asthma and chronic obstructive pulmonary disease (COPD), repeated injury and inflammation cause the airways to thicken, scar, and stiffen over time, narrowing the space air can flow through. These changes involve nearly every layer of the airway wall, from the inner lining to the surrounding muscle and blood supply, and they can become permanent enough that standard bronchodilator medications no longer fully open the airways.

What Actually Changes in a Remodeled Airway

Airway remodeling is not one single change but a collection of structural alterations that stack on top of each other. The main components include thickening of the smooth muscle that wraps around the airway, activation and multiplication of scar-producing cells called fibroblasts, accumulation of collagen and other structural proteins beneath the airway lining, damage and loss of the surface epithelial cells, excess mucus production, and growth of new blood vessels into the airway wall.^{1 2} These changes affect both the large central airways and the smaller peripheral ones, though not always in the same way.

The smooth muscle changes alone are worth unpacking. In asthma, the muscle cells around the airways can both enlarge individually and increase in number. Research examining airway tissue from people who died of asthma found that the enlargement of individual muscle cells happens in the large airways in both fatal and non-fatal cases, but an actual increase in the number of muscle cells shows up in both large and small airways only in fatal cases.³ That distinction matters because more muscle cells in the small airways create a much greater capacity for the airways to squeeze shut during an asthma attack.

Beyond the muscle, the connective tissue scaffold that holds the airway together, known as the extracellular matrix, gets reshaped. Extra collagen, fibronectin, and tenascin get deposited beneath the epithelium, and the balance between the enzymes that break down this matrix and the molecules that protect it shifts in favor of buildup.⁴ Experiments in animal models show that a growth factor called connective tissue growth factor tracks closely with the activity of these matrix-degrading enzymes and with the thickness of the smooth muscle layer, suggesting these processes reinforce each other.⁵

One striking experimental finding is that just stiffening the matrix, without adding any inflammatory signals at all, is enough to make airways hyperreactive. When researchers artificially crosslinked the collagen in airway tissue, doubling its stiffness, the airways constricted harder and faster when exposed to a constriction trigger.⁶ That finding upends the intuition that hyperreactivity is purely a problem of inflammation. Once the physical scaffolding changes, the airway misbehaves on its own.

Inflammation Is Not the Whole Story

Most people understandably assume that airway remodeling is just what happens after years of chronic inflammation. Inflammation certainly contributes, but one of the more surprising findings in the field is that mechanical forces alone, without any allergic or immune trigger, can kick off remodeling. A landmark trial published in the New England Journal of Medicine demonstrated this directly. Researchers challenged people with asthma using either an allergen (which causes both bronchoconstriction and eosinophilic inflammation) or methacholine (which constricts the airways but does not trigger allergic inflammation). Both groups developed similar remodeling changes: the collagen band beneath the epithelium thickened by about 2 micrometers, and mucus-producing cells increased by a comparable amount. The two groups were statistically indistinguishable from each other, even though only the allergen group had airway inflammation.⁷

The implication is that the physical squeezing of airway cells during bronchoconstriction generates enough compressive stress to trigger a repair response. The epithelial cells respond to being crushed by producing more fibronectin and collagen, ramping up mucus output, and shifting the enzyme balance toward tissue thickening.⁸ This creates a vicious cycle: bronchoconstriction causes remodeling, remodeling makes the next episode of bronchoconstriction worse, and the worsened constriction causes more remodeling.

How Epithelial Cells Change Identity

One of the more fascinating mechanisms driving remodeling is the ability of the cells lining the airway to essentially switch careers. When the epithelium is damaged repeatedly, some cells undergo a process in which they lose their surface-cell characteristics and start behaving like the connective tissue cells underneath. These transformed cells begin producing scar-like material, contributing to the fibrosis that thickens the airway wall. Growth factors and inflammatory molecules released after exposure to allergens, viruses, or pollutants can drive this transition.⁹ The resulting scar-producing cells are essentially fibroblasts born from the airway lining, which is one reason fibrosis in asthma is so tightly linked to epithelial damage.¹⁰

Another identity switch happens with mucus. Normally, the airway epithelium has a mix of cell types, including ciliated cells that sweep debris upward and a smaller number of mucus-secreting goblet cells. In remodeled airways, inflammation drives ciliated cells and other non-mucus cells to convert into goblet cells, a process called goblet cell metaplasia. The result is an airway lining overrun with mucus-producing cells, leading to the thick, plugging secretions that characterize severe asthma and COPD.¹¹ In asthma and COPD, elastic and collagen fiber remodeling in the airway walls combines with this mucus overproduction to produce the hallmark hyperreactivity of the airways.¹²

Environmental and Viral Triggers

Chronic airway inflammation from allergens gets the most attention, but environmental pollutants and early-life viral infections are major drivers of remodeling in their own right. Particulate matter, especially the fine particles known as PM2.5, can damage the airway epithelium, alter cell behavior, and promote the structural changes typical of remodeling.¹³ In mouse models of chronic asthma, PM2.5 exposure worsened remodeling by disrupting a clock-related protein in airway cells, which led to increased collagen production and more severe disease.¹⁴

On the viral side, respiratory syncytial virus (RSV) infections in early childhood appear to set up conditions for remodeling before asthma is even formally diagnosed. A study of preschool children with severe wheezing found that their airway epithelial cells had impaired wound-healing ability following RSV infection, along with reduced levels of a growth factor receptor critical for repair. Lower expression of this receptor correlated with greater collagen deposition in the airway wall.¹⁵ The take-home: early viral damage may leave the epithelium less able to repair itself normally, tipping it toward the kind of dysfunctional repair that produces fibrosis and thickening.

Remodeling Starts Earlier Than Expected

There is a lingering assumption that airway remodeling is something that develops over decades of poorly controlled adult asthma. The pediatric evidence argues otherwise. Signs of remodeling, including thickened basement membranes and increased smooth muscle, have been documented in children with asthma, and in some cases these structural changes appear even without detectable inflammation.¹⁶ A study comparing preschoolers with severe recurrent wheezing to school-age children found that basement membrane thickness increased with age, measuring about 3.8 micrometers in preschoolers versus 6.8 micrometers in older children.¹⁷

Increased airway smooth muscle is not even limited to asthma in children. A study of children with cystic fibrosis and non-cystic-fibrosis bronchiectasis found that both groups also had significantly more smooth muscle in their airways than healthy children, although the increase was greatest in asthma.¹⁸ This suggests that chronic airway inflammation from any cause, not just allergic inflammation, can trigger the remodeling machinery in growing lungs.

Blood Vessels and Nerves Remodel Too

Most discussions of airway remodeling focus on muscle and scar tissue, but two other components quietly make things worse. The first is the blood supply. Patients with asthma across all severity levels show increased numbers, size, and density of blood vessels in the airway wall, along with vascular leakage.¹⁹ This new blood vessel growth is driven largely by vascular endothelial growth factor (VEGF), which promotes the proliferation of vessel-lining cells and increases the permeability of existing vessels.²⁰ More vessels mean more swelling, more fluid leaking into the airway wall, and a thicker wall overall, which all further narrow the breathing passage.

The second underappreciated component is nerve remodeling. People with moderate persistent eosinophilic asthma have denser sensory nerve networks in their airway walls, along with higher expression of the irritant-signaling molecule substance P. This increased nerve density is associated with greater irritant sensitivity and less responsiveness to bronchodilators.²¹ Beyond sensory nerves, the cholinergic nerves that control airway muscle contraction also remodel: asthma patients show roughly double the density of these motor nerves around their smooth muscle compared to healthy individuals.²² More motor nerves feeding the muscle means a stronger and more hair-trigger contraction response, which helps explain why remodeled airways are so reactive even when inflammation is controlled.

How Asthma and COPD Remodel Differently

Asthma and COPD both involve airway remodeling, but the patterns are distinct. In asthma, the immune cells driving the process are predominantly eosinophils, mast cells, and a particular subset of T cells, and the earliest structural hallmark is thickening of the membrane just beneath the epithelium. In COPD, the inflammatory infiltrate is dominated by macrophages and a different subset of T cells, and the signature structural changes include squamous metaplasia of the epithelium (where the lining cells become flat and tough, losing their normal architecture), fibrosis of the airway wall, and destruction of the alveolar walls, something that does not happen in asthma.²³

CT imaging studies confirm these distinctions. When researchers compared airway wall measurements across generations of bronchi, asthma patients had greater wall area percentages and smaller internal airway areas than both COPD patients and healthy controls at every airway generation measured. COPD patients fell between asthmatics and controls, with less dramatic wall thickening but more emphysematous changes visible in the lung tissue itself.²⁴ The practical upshot: in asthma, the airway wall thickens inward and chokes the lumen; in COPD, the surrounding lung tissue breaks down and the small airways collapse. Both reduce airflow, but through different architectural failures.

What Remodeling Means for Lung Function

The clinical consequence that matters most to patients is irreversible airflow limitation, the kind that persists even after using a bronchodilator. A long-running population study tracking people from childhood into their mid-twenties found that those with persistently low lung function ratios after bronchodilator use showed roughly double the rate of decline in airflow compared to those with normal ratios. Male sex, childhood airway hyperresponsiveness, and low baseline lung function were all independent risk factors.²⁵

CT-based measurements reinforce the connection between structural changes and impaired function. In asthma patients, airway wall thickness measured on CT scans correlates negatively with standard lung function measures: the thicker the wall, the worse the airflow.²⁶ This is part of why some patients with long-standing asthma gradually develop a baseline level of obstruction that mimics COPD, sometimes called “fixed” airflow obstruction, where even the best medication regimen cannot fully reopen the airways.

Can Treatment Reverse Remodeling

For years, the assumption was that once remodeling set in, the structural changes were permanent. Inhaled corticosteroids, the backbone of asthma treatment, reduce inflammation effectively but have not consistently been shown to reverse the underlying architectural changes in the airway wall.²⁷ They can slow progression, manage symptoms, and reduce flare-ups, but the scar tissue and extra muscle tend to stay.

Biologic therapies, which target specific molecules in the inflammatory cascade, have changed the outlook. In some patients with severe asthma, biologics have led to the complete normalization of airflow obstruction that had been considered irreversible.²⁸ The improvements in lung function, mucus plugging, and structural changes seen with biologics can exceed those achieved with corticosteroids alone.²⁷ Not every patient responds this dramatically, and it remains unclear how much of the improvement reflects true structural reversal versus restoration of function through other means. But the early evidence has been genuinely surprising and has shifted the thinking from “remodeling is forever” to “remodeling might be at least partially reversible if you shut down the right pathways early enough.”

How Clinicians Detect Remodeling

Detecting remodeling in a living patient is not straightforward. The gold standard has traditionally been biopsy tissue obtained during bronchoscopy, which gives a direct look at the airway wall under a microscope. But biopsies are invasive, sample only a tiny area, and are not practical for routine monitoring.

High-resolution CT scanning can measure airway wall thickness non-invasively, and it reliably distinguishes asthma patients from healthy controls. However, standard CT has limitations: one study found that while it detected thicker walls in asthma patients overall, it could not differentiate between mild-to-moderate and severe disease.²⁹ A newer technique called optical coherence tomography, which uses light waves to create cross-sectional images during bronchoscopy, was able to pick up differences in the composition of the airway wall between severe and milder asthma. Both higher wall thickness on CT and greater scattering on optical coherence tomography were associated with worse asthma control.²⁹

There is growing interest in blood or sputum biomarkers that could reflect the degree of epithelial damage and remodeling without any imaging at all. Because different asthma subtypes involve different patterns of epithelial injury, identifying the right biomarkers could help clinicians figure out which patients are actively remodeling and tailor treatment accordingly.³⁰ This work is still early, but it represents a shift from treating remodeling as a pathology finding you can only see under a microscope to something you might track and intervene against in real time.